Observations — search entities
| Name ↑ | Type | Sources | In observations | Aliases |
|---|---|---|---|---|
| Sendai virus | drug | 2 | 1 | |
| senile plaques | phenotype | 2 | 2 | |
| sensitization | phenotype | 7 | 3 | greater sensitization |
| sensorimotor gating | phenotype | 2 | 1 | |
| sensory deficits | phenotype | 5 | 1 | Sensory deficits |
| Separated | phenotype | 4 | — | |
| Separation | phenotype | 2 | 1 | |
| separation anxiety disorder | phenotype | 7 | 5 | |
| sepsis | phenotype | 2 | 1 | |
| Sequenom | drug | 3 | 1 | Sequenom Inc., Sequenom® |
| SERINC2 | gene | 4 | 2 | Serinc2, serine incorporator 2 |
| SERINC2 SNPs | variant | 2 | 2 | |
| serine | drug | 4 | 3 | |
| serious mental illness | phenotype | 4 | 2 | severe mental illness |
| serious physical illness | phenotype | 6 | 4 | Serious physical illnesses, physical illness |
| Serotonergic system | drug | 3 | 2 | serotonergic, serotoninergic system |
| serotonin | drug | 57 | 46 | 5-HT, 5-hydroxytryptamine, 5HT, CNS serotonin, brain serotonin, monoamine serotonin, serotonergic, serotonergic transmission, serotonin, serotonin transport |
| Serotonin reuptake inhibitors | drug | 2 | 1 | SRIs |
| SERPINC1 | gene | 3 | 1 | |
| sertraline | drug | 4 | 1 | SERT |